×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Akkermansia muciniphila in CNS Disorders
therapeutic
1,224 words
KG: Akkermansia
2026-03-24
kind:therapeutic
section:therapeutics
state:published
Contents
Akkermansia muciniphila in CNS Disorders
💊
Therapeutic Info
Name
Akkermansia muciniphila in CNS Disorders
Summary
Page for Akkermansia muciniphila in CNS Disorders
Related Diseases
Alzheimer's disease
Knowledge Graph
Related Hypotheses (3)
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Related Analyses (15)
Systemic immune profiling and peripheral immune contribution
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed
How can AQP4 be effectively targeted therapeutically to impr
neurodegeneration · failed
What are the specific molecular mechanisms by which AQP4 dys
neurodegeneration · failed
How can CNS-selective HDAC/DNMT inhibitors be developed to a
pharmacology · failed
Does CXCL10 inhibition compromise CNS immune surveillance du
neuroimmunology · failed
How can CRISPR systems achieve persistent therapeutic effect
gene therapy · failed
What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Show 10 more
Related Experiments (5)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
TLR expression analysis in Parkinson's disease patients
clinical · proposed · Score: 0.85
TLR4 Activation Assay with NETs and Anti-CarP Antibodies
exploratory · proposed · Score: 0.85
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
Knowledge Graph (1 edges)
Akkermansia
protects_against
Alzheimer's disease